Han Cheng

1.3k total citations
42 papers, 967 citations indexed

About

Han Cheng is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Han Cheng has authored 42 papers receiving a total of 967 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 22 papers in Epidemiology and 11 papers in Molecular Biology. Recurrent topics in Han Cheng's work include Viral Infections and Outbreaks Research (15 papers), Viral Infections and Vectors (12 papers) and Influenza Virus Research Studies (7 papers). Han Cheng is often cited by papers focused on Viral Infections and Outbreaks Research (15 papers), Viral Infections and Vectors (12 papers) and Influenza Virus Research Studies (7 papers). Han Cheng collaborates with scholars based in United States, China and Norway. Han Cheng's co-authors include Lijun Rong, Norton P. Peet, Chih-chen Wang, Gene G. Olinger, Calli M. Lear-Rooney, Balaji Manicassamy, Qinghua Cui, Ruikun Du, Zheng W. Chen and Michael Caffrey and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Cancer Research.

In The Last Decade

Han Cheng

41 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Han Cheng United States 20 360 344 318 119 79 42 967
Dolores Limongi Italy 16 175 0.5× 239 0.7× 307 1.0× 203 1.7× 35 0.4× 39 1.1k
Girdhar M. Taori India 22 614 1.7× 520 1.5× 425 1.3× 126 1.1× 35 0.4× 81 1.8k
Veronica Soloveva United States 18 319 0.9× 181 0.5× 355 1.1× 87 0.7× 28 0.4× 34 915
Kirstin Mösbauer Germany 5 397 1.1× 150 0.4× 197 0.6× 78 0.7× 30 0.4× 5 681
Dedong Li China 20 506 1.4× 195 0.6× 377 1.2× 172 1.4× 25 0.3× 51 1.1k
Stephen S. Hwang United States 17 531 1.5× 174 0.5× 314 1.0× 376 3.2× 25 0.3× 38 1.8k
Sheikh Arslan Sehgal Pakistan 19 183 0.5× 347 1.0× 710 2.2× 298 2.5× 76 1.0× 53 1.3k
Soumaya Zlitni United States 15 257 0.7× 87 0.3× 574 1.8× 38 0.3× 34 0.4× 20 1.0k
Jin Soo Shin South Korea 14 311 0.9× 184 0.5× 186 0.6× 112 0.9× 11 0.1× 32 797

Countries citing papers authored by Han Cheng

Since Specialization
Citations

This map shows the geographic impact of Han Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Han Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Han Cheng more than expected).

Fields of papers citing papers by Han Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Han Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Han Cheng. The network helps show where Han Cheng may publish in the future.

Co-authorship network of co-authors of Han Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Han Cheng. A scholar is included among the top collaborators of Han Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Han Cheng. Han Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qiu, Yong, Qingyang Zhang, Shuang Cheng, et al.. (2023). SOX2 downregulation of PML increases HCMV gene expression and growth of glioma cells. PLoS Pathogens. 19(4). e1011316–e1011316. 10 indexed citations
2.
Sandeep, Bhushan, Han Cheng, Yang Li, et al.. (2022). Assessing Right Ventricle Pulmonary Artery Coupling and Uncoupling Using Echocardiography and Cardiopulmonary Exercise Test in Post Operative TOF Patients. Current Problems in Cardiology. 48(8). 101214–101214. 4 indexed citations
3.
Sarute, Nicolás, et al.. (2021). Signal-regulatory protein alpha is an anti-viral entry factor targeting viruses using endocytic pathways. PLoS Pathogens. 17(6). e1009662–e1009662. 13 indexed citations
4.
Amaya, Moushimi, Han Cheng, Viktoriya Borisevich, et al.. (2021). A recombinant Cedar virus based high-throughput screening assay for henipavirus antiviral discovery. Antiviral Research. 193. 105084–105084. 11 indexed citations
5.
Xiong, Rui, Laura Cooper, Hyun Lee, et al.. (2021). Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry. PLoS Pathogens. 17(2). e1009312–e1009312. 22 indexed citations
6.
Cheng, Han, Bhushan Sandeep, Na Li, Zongwei Xiao, & Ke Gao. (2021). Preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are correlated with tumor–node–metastasis stages in patients with non-small cell lung cancer. Journal of Cancer Research and Therapeutics. 18(6). 1666–1673. 6 indexed citations
7.
Du, Ruikun, Han Cheng, Qinghua Cui, et al.. (2021). Identification of a novel inhibitor targeting influenza A virus group 2 hemagglutinins. Antiviral Research. 186. 105013–105013. 19 indexed citations
8.
Huang, Shengnan, et al.. (2021). Hearing Loss Caused by HCMV Infection through Regulating the Wnt and Notch Signaling Pathways. Viruses. 13(4). 623–623. 8 indexed citations
9.
Antanasijevic, Aleksandar, Han Cheng, Irina N. Gaisina, et al.. (2020). Structure of avian influenza hemagglutinin in complex with a small molecule entry inhibitor. Life Science Alliance. 3(8). e202000724–e202000724. 20 indexed citations
10.
Cheng, Han, et al.. (2020). Development of coumarine derivatives as potent anti-filovirus entry inhibitors targeting viral glycoprotein. European Journal of Medicinal Chemistry. 204. 112595–112595. 18 indexed citations
11.
Cheng, Han, Smanla Tundup, Aleksandar Antanasijevic, et al.. (2020). Identification of entry inhibitors with 4-aminopiperidine scaffold targeting group 1 influenza A virus. Antiviral Research. 177. 104782–104782. 16 indexed citations
12.
Cheng, Han, Rui Xiong, Veronica Soloveva, et al.. (2018). Repurposing potential of 1st generation H1-specific antihistamines as anti-filovirus therapeutics. Antiviral Research. 157. 47–56. 23 indexed citations
13.
Cheng, Han, Veronica Soloveva, Dima Gharaibeh, et al.. (2017). Identification of a coumarin-based antihistamine-like small molecule as an anti-filoviral entry inhibitor. Antiviral Research. 145. 24–32. 30 indexed citations
14.
Shen, Hongbo, Feifei Wang, Gucheng Zeng, et al.. (2016). Bis-biguanide dihydrochloride inhibits intracellular replication of M. tuberculosis and controls infection in mice. Scientific Reports. 6(1). 32725–32725. 11 indexed citations
15.
Cheng, Han, et al.. (2016). A High-Throughput Screening Platform Targeting PDLIM5 for Pulmonary Hypertension. SLAS DISCOVERY. 21(4). 333–341. 13 indexed citations
16.
Wang, Minxiu, et al.. (2015). Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry. Journal of Virology. 89(10). 5441–5449. 49 indexed citations
17.
Antanasijevic, Aleksandar, Han Cheng, Duncan J. Wardrop, Lijun Rong, & Michael Caffrey. (2013). Inhibition of Influenza H7 Hemagglutinin-Mediated Entry. PLoS ONE. 8(10). e76363–e76363. 27 indexed citations
18.
Cheng, Han, Lei Wang, & Chih-chen Wang. (2009). Domain a’ of protein disulfide isomerase plays key role in inhibiting α-synuclein fibril formation. Cell Stress and Chaperones. 15(4). 415–421. 33 indexed citations
19.
Huang, Chunjuan, Han Cheng, Hui Zhou, et al.. (2006). Heat Shock Protein 70 Inhibits α-Synuclein Fibril Formation via Interactions with Diverse Intermediates. Journal of Molecular Biology. 364(3). 323–336. 92 indexed citations
20.
Cheng, Han. (2000). Location of the Deleted Sequence of Spontaneously Deleted RNAs of Beet Necrotic Yellow Vein Virus NM lsolate. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026